AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Bio-Techne Corporation (TECH)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

65.19

-0.75 (-1.14%)

At close: Feb 18, 2025, 3:59 PM

65.03

-0.25%

After-hours: Feb 18, 2025, 07:37 PM EST

undefined% (undefined)

Bid	65.03
Market Cap	10.31B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.98
PE Ratio (ttm)	66.52
Forward PE	n/a
Analyst	Buy

Ask	66.57
Volume	1,105,955
Avg. Volume (20D)	1,040,691
Open	66.09
Previous Close	65.94
Day's Range	64.41 - 66.66
52-Week Range	61.16 - 85.57
Beta	undefined

About TECH

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene ther...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Feb 9, 1989

Employees 3,100

Stock Exchange NASDAQ

Ticker Symbol TECH

Website https://www.bio-techne.com

Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for TECH stock is "Buy." The 12-month stock price forecast is $85, which is an increase of 30.39% from the latest price.

Buy 71.43%

Hold 28.57%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Bio-Techne Corporation is scheduled to release its earnings on Apr 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

+3.72%

Bio-Techne shares are trading higher after the com... Unlock content with Pro Subscription

2 months ago

+4.36%

Bio-Techne shares are trading higher after Gemini Bioproducts acquired the company's product rights and inventory of selected fetal bovine serum.

News

1 week ago · zacks.com

EXEL or TECH: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to v...

2 weeks ago · zacks.com

Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket

TECH registers continued growth momentum across its Diagnostics & Spatial Biology segment.

2 weeks ago · seekingalpha.com

Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript

Bio-Techne Corporation (NASDAQ:TECH ) Q2 2025 Earnings Conference Call February 5, 2025 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President and Ch...

1 week ago · zacks.com

Techne (TECH) Tops Q2 Earnings and Revenue Estimates

Techne (TECH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.40 per share a year ago.

2 weeks ago · zacks.com

Can These 5 MedTech Stocks Hit Earnings Targets This Season?

Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.

2 weeks ago · zacks.com

TECH Gears Up to Report Q2 Earnings: Here's What to Expect

In the second quarter, Bio-Techne is expected to have witnessed the stabilization of large-pharma customers and an increase in biotech customers' ordering trends.

4 weeks ago · zacks.com

EXEL vs. TECH: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and Techne (TECH). But which of these two companies is the best option for those looking for u...

1 month ago · zacks.com

TECH Stock Might Rise From the Expansion of Designer Protein Portfolio

Bio-Techne launches AI-engineered designer proteins to advance cell therapy and regenerative medicine.

1 month ago · zacks.com

BMRN or TECH: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Techne (TECH). But which of these two stocks presents inves...

1 month ago · zacks.com

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?

TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic characterization and development processes.

Load More News